137 related articles for article (PubMed ID: 3332090)
1. The role of pentostatin (2'-deoxycoformycin, dCF) in the management of lymphoproliferative malignancies.
Spiers AS
Blood Rev; 1987 Jun; 1(2):106-10. PubMed ID: 3332090
[TBL] [Abstract][Full Text] [Related]
2. 2'-Deoxycoformycin (pentostatin) for lymphoid malignancies. Rational development of an active new drug.
O'Dwyer PJ; Wagner B; Leyland-Jones B; Wittes RE; Cheson BD; Hoth DF
Ann Intern Med; 1988 May; 108(5):733-43. PubMed ID: 3282467
[TBL] [Abstract][Full Text] [Related]
3. The treatment of hairy-cell leukaemia with 2'-deoxycoformycin.
Johnston JB; Glazer RI; Pugh L; Israels LG
Br J Haematol; 1986 Jul; 63(3):525-34. PubMed ID: 3488071
[TBL] [Abstract][Full Text] [Related]
4. The treatment of hairy cell leukemia (HCL) with pentostatin (2'-deoxycoformycin, dCF).
Spiers AS; Parekh SJ
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():173-5. PubMed ID: 2653498
[No Abstract] [Full Text] [Related]
5. Effectiveness of pentostatin (2'-deoxycoformycin) in refractory lymphoid neoplasms.
Spiers AS; Ruckdeschel JC; Horton J
Scand J Haematol; 1984 Feb; 32(2):130-4. PubMed ID: 6608139
[TBL] [Abstract][Full Text] [Related]
6. Pentostatin (2'deoxycoformycin) for the treatment of lymphoid neoplasms.
Ho AD; Thaler J; Willemze R; Lauria F; Derossi G; Kuse R; Stryckmans P; Blanc CM; Cataldo F; McVie G
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():60-2. PubMed ID: 2653520
[TBL] [Abstract][Full Text] [Related]
7. Remissions in hairy-cell leukemia with pentostatin (2'-deoxycoformycin).
Spiers AS; Moore D; Cassileth PA; Harrington DP; Cummings FJ; Neiman RS; Bennett JM; O'Connell MJ
N Engl J Med; 1987 Apr; 316(14):825-30. PubMed ID: 2434850
[TBL] [Abstract][Full Text] [Related]
8. Clinical trials in hairy cell leukemia. Current status and future directions.
Cheson BD; Martin A
Ann Intern Med; 1987 Jun; 106(6):871-8. PubMed ID: 3555204
[TBL] [Abstract][Full Text] [Related]
9. The clinical pharmacology of the adenosine deaminase inhibitor 2'-deoxycoformycin.
Smyth JF; Paine RM; Jackman AL; Harrap KR; Chassin MM; Adamson RH; Johns DG
Cancer Chemother Pharmacol; 1980; 5(2):93-101. PubMed ID: 6970630
[TBL] [Abstract][Full Text] [Related]
10. Clinical, pharmacologic, and immunologic effects of 2'-deoxycoformycin.
Cummings FJ; Crabtree GW; Wiemann MC; Spremulli EN; Parks RE; Calabresi P
Clin Pharmacol Ther; 1988 Nov; 44(5):501-9. PubMed ID: 3263248
[TBL] [Abstract][Full Text] [Related]
11. Deoxycoformycin in therapy of refractory lymphoid neoplasms.
Ho AD; Thaler J; Kuse R; Willemze R; Mandelli F; Lauria F; Zittoun R; Stryckmans P
Onkologie; 1988 Feb; 11(1):35-7. PubMed ID: 3283623
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic selectivity of and predication of response to 2'-deoxycoformycin in acute leukaemia.
Prentice HG; Russell NH; Lee N; Ganeshaguru K; Blacklock H; Piga A; Smyth JF; Hoffbrand AV
Lancet; 1981 Dec; 2(8258):1250-4. PubMed ID: 6118669
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of 2'-deoxycoformycin in hairy-cell leukemia: a study of the National Cancer Institute of Canada Clinical Trials Group.
Johnston JB; Eisenhauer E; Corbett WE; Scott JG; Zaentz SD
J Natl Cancer Inst; 1988 Jul; 80(10):765-9. PubMed ID: 3290498
[TBL] [Abstract][Full Text] [Related]
14. Response to pentostatin in hairy-cell leukemia refractory to interferon-alpha. The European Organization for Research and Treatment of Cancer Leukemia Cooperative Group.
Ho AD; Thaler J; Mandelli F; Lauria F; Zittoun R; Willemze R; McVie G; Marmont AM; Prümmer O; Stryckmans P
J Clin Oncol; 1989 Oct; 7(10):1533-8. PubMed ID: 2789273
[TBL] [Abstract][Full Text] [Related]
15. Pentostatin in the treatment of advanced hairy cell leukemia.
Kraut EH; Bouroncle BA; Grever MR
J Clin Oncol; 1989 Feb; 7(2):168-72. PubMed ID: 2783731
[TBL] [Abstract][Full Text] [Related]
16. Pentostatin in chronic lymphocytic leukemia: a phase II trial of Cancer and Leukemia group B.
Dillman RO; Mick R; McIntyre OR
J Clin Oncol; 1989 Apr; 7(4):433-8. PubMed ID: 2784491
[TBL] [Abstract][Full Text] [Related]
17. Deoxycoformycin in the treatment of leukemias and lymphomas.
Smyth JF; Prentice HG; Proctor S; Hoffbrand AV
Ann N Y Acad Sci; 1985; 451():123-8. PubMed ID: 3878113
[TBL] [Abstract][Full Text] [Related]
18. Phase I study of 2'-deoxycoformycin in acute lymphoblastic leukemia.
Poplack DG; Sallan SE; Rivera G; Holcenberg J; Murphy SB; Blatt J; Lipton JM; Venner P; Glaubiger DL; Ungerleider R; Johns D
Cancer Res; 1981 Sep; 41(9 Pt 1):3343-6. PubMed ID: 6973390
[TBL] [Abstract][Full Text] [Related]
19. 2'-Deoxycoformycin (Pentostatin) in hairy cell leukemia: response in patients refractory to interferon alpha.
Ho AD; Kuse R; Prümmer O; Porzsolt F; Hunstein W
Klin Wochenschr; 1987 Oct; 65(20):975-9. PubMed ID: 3501501
[TBL] [Abstract][Full Text] [Related]
20. Treatment of cutaneous T cell lymphoma with 2'-deoxycoformycin (pentostatin).
Dang-Vu AP; Olsen EA; Vollmer RT; Greenberg ML; Hershfield MS
J Am Acad Dermatol; 1988 Oct; 19(4):692-8. PubMed ID: 3263401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
